377 related articles for article (PubMed ID: 15889298)
1. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Clemons KV; Espiritu M; Parmar R; Stevens DA
Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Elter T; Sieniawski M; Gossmann A; Wickenhauser C; Schröder U; Seifert H; Kuchta J; Burhenne J; Riedel KD; Fätkenheuer G; Cornely OA
Int J Antimicrob Agents; 2006 Sep; 28(3):262-5. PubMed ID: 16908120
[TBL] [Abstract][Full Text] [Related]
4. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
5. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Shlobin OA; Dropulic LK; Orens JB; Mcdyer JF; Conte JV; Yang SY; Girgis R
J Heart Lung Transplant; 2005 Nov; 24(11):1991-4. PubMed ID: 16297812
[TBL] [Abstract][Full Text] [Related]
7. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Howell A; Midturi J; Sierra-Hoffman M; Carpenter J; Hurley D; Winn R
Med Mycol; 2005 Nov; 43(7):651-5. PubMed ID: 16396251
[TBL] [Abstract][Full Text] [Related]
8. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Tsiodras S; Zafiropoulou R; Giotakis J; Imbrios G; Antoniades A; Manesis EK
Transpl Infect Dis; 2004 Mar; 6(1):37-40. PubMed ID: 15225226
[TBL] [Abstract][Full Text] [Related]
9. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus mediastinitis after cardiac surgery.
Caballero MJ; Mongardon N; Haouache H; Vodovar D; Ben Ayed I; Auvergne L; Hillion ML; Botterel F; Dhonneur G
Int J Infect Dis; 2016 Mar; 44():16-9. PubMed ID: 26845443
[TBL] [Abstract][Full Text] [Related]
11. Combination antifungal therapy for invasive aspergillosis.
Cesaro S; Visintin G
Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
[No Abstract] [Full Text] [Related]
12. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
[TBL] [Abstract][Full Text] [Related]
13. Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
Levin T; Suh B; Beltramo D; Samuel R
Transpl Infect Dis; 2004 Sep; 6(3):129-31. PubMed ID: 15569230
[TBL] [Abstract][Full Text] [Related]
14. [Efficacies and clinical roles of new antifungal agents].
Tokimatsu I; Kadota J
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
[TBL] [Abstract][Full Text] [Related]
16. Multi-azole resistance in Aspergillus fumigatus.
Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
[TBL] [Abstract][Full Text] [Related]
17. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Verma A; Williams S; Trifilio S; Zembower T; Mehta J
Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
[No Abstract] [Full Text] [Related]
19. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Sims-McCallum RP
Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
[No Abstract] [Full Text] [Related]
20. Caspofungin versus liposomal amphotericin B for empirical therapy.
Danaher PJ
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
